### Evidence Statement CG15AdultES185
In the management of people with diabetes and new or established vascular disease, the SIGN guidelines 174 re fer to a meta-analysis of platelet inhibitor therapy demonstrating a 31% re duction in non-fatal reinfarction, a 42% reduction in non-fatal stroke and a 13% reduction in arterial mortality



[@Linden_2011]
